KKR (NYSE:KKR) shares gained ground Thursday. The company announced the launch of Allyntra, a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion.
Robbie Atkinson will be appointed as Chief Executive Officer of Allyntra and Brian Highley as Chairman. Together, they bring deep experience building and scaling global manufacturing organizations through operational excellence and strategic leadership.
Most recently, Atkinson served as CEO and President of Medical Manufacturing Technologies (MMT), where he led the company’s strategy, operations, and growth through a period of significant expansion, culminating in its successful sale to Perimeter Solutions, Inc. (NYSE: PRM).
Highley brings more than 30 years of experience across the medical technology industry, having previously served as CEO of Cirtec, where he scaled the company meaningfully from two sites into one of the leading providers of end-to-end services to medical technology OEMs, including design, engineering, prototyping, and manufacturing solutions.
KKR shares picked up 54 cents to $93.84, while those for PRM advanced $1.48, or 4.4%, to $35.27.
Related Stories
